Gaborcon (Hainan) Holding Co., Ltd.

Shanghai Aston Medical Technology Co., Ltd. is registered in Fengxian District, Shanghai, with a registered capital of 10 million yuan. It is an enterprise engaged in technical services, technology development, technical consultation and promotion, enterprise management, hospital management, food operation and production. The company has always been committed to cell biotechnology research and achievement transformation, while carrying out research on the rehabilitation of difficult and chronic diseases and the global promotion and application of international anti-aging new technologies. It is a global health company. The company currently has a number of globally leading biotechnology achievements that are ready for transformation and commercialization. Among them, the liposome-encapsulated macromolecular active polypeptide technology series achievements declared in a number of invention patents are the only globally leading anti-aging technology achievements representing China to participate in the World Anti-Aging Medical Conference in the past 27 years and causing a sensation. It is also currently the only globally leading biotechnology achievement that can promote cell repair and regeneration through oral administration. As a scientific research and innovation-oriented enterprise, the company has a number of international and domestic scientific research experts and medical experts, dedicated to the research and transformation of life science and biotechnology products, aiming to solve the problems of aging, disease prevention and rehabilitation faced by human beings. In addition to the existing globally leading biotechnology achievements, the newly developed patent achievements combining traditional Chinese 'medicine and food homology' and 'biotechnology' are also being declared, which will provide strong scientific and technological support for the realization of the grand goal of the 'Healthy China 2030' plan.